Dynamikos tackles complex, multifaceted problems that defy conventional approaches. We combine advanced informatics, an interactive domain-crossing view of scientific issues, and creative approaches to financing to develop solutions to problems such as the causes and prevention of neurological disease, non-pesticide insect control, and other socio-economic health related concerns.
Activity:
- Informatics
- Licensing & Business Development
- Research & Development
Product / Technology type(s) covered:
- Bio
- Curative
- Diagnostics
- Generics
- Preventive
- Proteins
- Reagents
- Technology
Therapeutic targets:
- Alzheimer's Disease
- Genetics
- Infectious Diseases
- Neurology
- Ophthalmology
|
|
Markets Covered
a. HeadQuarter: Canada
b. Continent(s) active:
North America
, Europe
, Australia/New-Zealand
, Central/South America
, Far East
, Near/Middle East
, Africa
, Asia
c. Countries active: Unite States, Canada, Europe, Australia, South America
Corporate data:
Number of Employees: 6
Turnover:
Amount: |
Year: |
Currency: |
Private |
2002 |
US Dollar |
Year founded: 2003
Partners / Alliances: Dynamikos is a Nevada, U.S.A. corporation, having its corporate headquarters located in Vancouver, British Columbia, Canada. Shaw Neural Dynamics Corporation, a subsidiary of Dynamikos, is a privately-held Vancouver based biotechnology company dedicated to the prevention of cytoskeletal disorders which include Alzheimers (AD), Parkinson’s (PD) and Lou Gehrig’s disease (ALS).
|